Your browser doesn't support javascript.
loading
A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.
Sutton, J A; Clauss, R P.
Affiliation
  • Sutton JA; a ReGen Therapeutics plc and Guildford Clinical Pharmacology Ltd. , Midhurst , West Sussex , UK.
  • Clauss RP; b Department of Nuclear Medicine , Royal Surrey County Hospital , Guildford , Surrey , UK.
Brain Inj ; 31(8): 1019-1027, 2017.
Article in En | MEDLINE | ID: mdl-28534652
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Brain Injuries / Hypnotics and Sedatives / Nervous System Diseases Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Brain Inj Journal subject: CEREBRO Year: 2017 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Brain Injuries / Hypnotics and Sedatives / Nervous System Diseases Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Brain Inj Journal subject: CEREBRO Year: 2017 Document type: Article Country of publication: Reino Unido